
Kaleido Biosciences KLDO
Kaleido Biosciences P/E | KLDO
P/E Jährlich Kaleido Biosciences
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.816 | -6.13 | -2.55 | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -0.816 | -6.13 | -3.17 |
P/E anderer Aktien in der Pharmaeinzelhändler
| Name | P/E | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
AbbVie
ABBV
|
220 | $ 263.04 | 0.49 % | $ 465 B | ||
|
AbCellera Biologics
ABCL
|
-6.57 | $ 11.41 | 2.15 % | $ 3.41 B | ||
|
Фармсинтез
LIFE
|
-3.81 | - | - | - | ||
|
Aclaris Therapeutics
ACRS
|
-5.93 | $ 5.53 | 6.02 % | $ 678 M | ||
|
ADC Therapeutics SA
ADCT
|
-0.971 | $ 1.09 | 3.74 % | $ 139 M | ||
|
Amryt Pharma plc
AMYT
|
2.55 K | - | - | $ 621 M | ||
|
Evelo Biosciences
EVLO
|
-0.236 | - | -14.46 % | $ 27.9 M | ||
|
Allakos
ALLK
|
-0.612 | - | - | $ 28.6 M | ||
|
Checkmate Pharmaceuticals
CMPI
|
-0.859 | - | - | $ 231 M | ||
|
Clovis Oncology
CLVS
|
-4.07 | - | -7.23 % | $ 13 M | ||
|
Chimerix
CMRX
|
-1.26 | - | - | $ 756 M | ||
|
Concert Pharmaceuticals
CNCE
|
-1.3 | - | - | $ 401 M | ||
|
ADMA Biologics
ADMA
|
25.7 | $ 8.61 | 0.16 % | $ 2.05 B | ||
|
Eiger BioPharmaceuticals
EIGR
|
-0.0416 | - | -9.21 % | $ 2.55 M | ||
|
89bio
ETNB
|
-2.66 | - | - | $ 1.55 B | ||
|
Freeline Therapeutics Holdings plc
FRLN
|
-2.93 | - | - | $ 384 M | ||
|
Fusion Pharmaceuticals
FUSN
|
-14.6 | - | - | $ 1.41 B | ||
|
Guardion Health Sciences
GHSI
|
-0.476 | - | -0.31 % | $ 3.64 M | ||
|
Genocea Biosciences
GNCA
|
-2.19 | - | -15.0 % | $ 3.04 M | ||
|
Gritstone Oncology
GRTS
|
-1.99 | - | 0.42 % | $ 213 M | ||
|
G1 Therapeutics
GTHX
|
-3.61 | - | - | $ 370 M | ||
|
Harpoon Therapeutics
HARP
|
-0.318 | - | - | $ 763 M | ||
|
Humanigen
HGEN
|
-0.177 | - | -81.12 % | $ 4.28 M | ||
|
HOOKIPA Pharma
HOOK
|
-0.0823 | - | -6.92 % | $ 79.4 M | ||
|
Intercept Pharmaceuticals
ICPT
|
-33.9 | - | - | $ 643 M | ||
|
IGM Biosciences
IGMS
|
-0.433 | - | - | $ 76.9 M | ||
|
IMV
IMV
|
-0.18 | - | - | $ 13.1 M | ||
|
Intra-Cellular Therapies
ITCI
|
-785 | - | - | $ 13.6 B | ||
|
Kinnate Biopharma
KNTE
|
-1.1 | - | - | $ 123 M | ||
|
Chinook Therapeutics
KDNY
|
-7.41 | - | - | $ 2.6 B | ||
|
Kronos Bio
KRON
|
-0.615 | - | 1.49 % | $ 50.8 M | ||
|
Karuna Therapeutics
KRTX
|
-27.2 | - | - | $ 12.2 B | ||
|
Landos Biopharma
LABP
|
-2.19 | - | 0.58 % | $ 144 M | ||
|
La Jolla Pharmaceutical Company
LJPC
|
6.46 | - | - | $ 154 M | ||
|
LogicBio Therapeutics
LOGC
|
-1.87 | - | - | $ 229 M | ||
|
Lumos Pharma
LUMO
|
-0.723 | - | - | $ 35.3 M | ||
|
Merrimack Pharmaceuticals
MACK
|
-179 | - | - | $ 216 M | ||
|
Stealth BioTherapeutics Corp
MITO
|
-8.57 | - | - | $ 23.9 M | ||
|
Mirati Therapeutics
MRTX
|
-3.46 | - | - | $ 3.3 B | ||
|
NexImmune
NEXI
|
-0.113 | - | 70.13 % | $ 4.12 M | ||
|
9 Meters Biopharma
NMTR
|
-0.4 | - | -42.97 % | $ 1.05 M | ||
|
InVivo Therapeutics Holdings Corp.
NVIV
|
-0.3 | - | -37.48 % | $ 476 K | ||
|
Nymox Pharmaceutical Corporation
NYMX
|
-4.17 | - | -19.68 % | $ 18.4 M | ||
|
ObsEva SA
OBSV
|
-1.88 | - | -15.52 % | $ 10.5 M | ||
|
Oncorus
ONCR
|
-0.00011 | - | -8.54 % | $ 3.19 M | ||
|
OncoSec Medical Incorporated
ONCS
|
-0.517 | - | 31.87 % | $ 1.61 M | ||
|
Oncternal Therapeutics
ONCT
|
-0.692 | - | -24.12 % | $ 1.56 M | ||
|
Opiant Pharmaceuticals
OPNT
|
38.7 | - | - | $ 109 M | ||
|
Orchard Therapeutics plc
ORTX
|
-4.46 | - | 1.02 % | $ 90.8 M |